The Xrp1 protein appears to play an important role in the development of certain forms of ALS and dementia caused by a mutation in the FUS gene. This finding of Radboud University researchers was published on September 12th ...
Sep 14, 2018
0
24
(HealthDay)—The decision to overturn the End of Life Option Act has added stress and anxiety to terminally ill patients, including those with amyotrophic lateral sclerosis (ALS), according to a patient testimonial published ...
Sep 5, 2018
0
0
A mechanism for amyotrophic lateral sclerosis (ALS) development has been discovered at Umeå University, Sweden. The researchers report that proteins with a defect structure spread the deformation to other proteins. The discovery ...
Sep 4, 2018
0
129
Laboratory studies have shown the potential for patients with amyotrophic lateral sclerosis (ALS), who cannot move or speak, to communicate using a brain-computer interface (BCI). In the first study of independent in-home ...
Aug 30, 2018
0
49
NIH-funded researchers delayed signs of amyotrophic lateral sclerosis (ALS) in rodents by injecting them with a second-generation drug designed to silence the gene, superoxide dismutase 1 (SOD1). The results, published in ...
Jul 26, 2018
0
13
Researchers from the University of Liverpool have identified a new compound that protects against neurodegeneration in nematode worms. The discovery may enable novel treatments for human neurodegenerative diseases to be developed ...
Jul 18, 2018
0
4
Nearly all major neurodegenerative diseases—from Alzheimer's to Parkinson's—are defined and diagnosed by the presence of one of four proteins that have gone rogue: tau, amyloid-beta (Aβ), alpha-synuclein (α-syn), or ...
Jul 5, 2018
0
17
Thousands of people took the Ice Bucket Challenge, a sensation in the summer of 2014. Participants were filmed dumping buckets of ice-cold water on their heads and challenging their friends to do the same. Challenged participants ...
Jun 27, 2018
0
4
New clues may help improve speech for people with dysarthria, a type of speech disorder commonly found in patients with amyotrophic lateral sclerosis (ALS).
May 28, 2018
0
7
A new gene therapy for treating an inherited form of Amyotrophic Lateral Sclerosis has been given an Orphan Drug designation by the European Medicines Agency. The therapy is already in preclinical development at EPFL.
May 23, 2018
0
84
